Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Ireland and UK or involving organisations from these countries.

Total search results: 2805 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Erytech–Leucadia: investor conference, 201811 supply service Erytech at Jefferies London Healthcare Conference 2018 2018-11-14
Gotham Therapeutics–Alexandria Real Estate: investment, 201810 financing round Series A totalling $54m incl co-investor Alexandria Venture Investments 2018-10-10
Gotham Therapeutics–Celgene: investment, 201810 financing round Series A totalling $54m incl co-investor Celgene Corp 2018-10-10
Gotham Therapeutics–Forbion: investment, 201810 financing round Series A totalling $54m incl $15m from co-lead investor Forbion IV Fund 2018-10-10
Gotham Therapeutics–GSK: investment, 201810 financing round Series A totalling $54m incl co-lead investor SR One 2018-10-10
Gotham Therapeutics–SEVERAL: investment, 201810 financing round Series A $54m co-led by Versant Ventures + Forbion + SR One 2018-10-10
Gotham Therapeutics–Versant Ventures: investment, 201810 financing round Series A totalling $54m incl founding + co-lead investor Versant Ventures 2018-10-10
MeiraGTx–Chardan: investor conference, 201810 supply service MeiraGTx presents at Chardan Genetic Medicines Conference in New York 2018-10-09
MeiraGTx–W2O Group: public relations, 201810 service existent PR by W2O pure 2018-10-09
Vector Neurosciences–MeiraGTx: investment, 201810 acquisition in all-stock transaction by MeiraGTx 2018-10-05
Axcelead–ERS Genomics: CRISPR technology, 201810– license non-excl ww to CRISPR/Cas9 genome editing IP of ERS Genomics Ltd 2018-10-04
GenAhead Bio–ERS Genomics: CRISPR technology, 201810– license non-excl to CRISPR/Cas9 genome editing IP of ERS Genomics Ltd 2018-10-04
Iqvia–United Kingdom (govt): clinical genomics, 201810– collab to develop integrated platform with clinical + genomics data with Genomics England 2018-10-04
Evonetix–Magic Micro: DNA synthesis technology, 201810– collab developm of MEMS for DNA synthesis with LioniX Intl 2018-10-01
Forbion–SEVERAL: investment, 201810 final close €360m of Forbion IV fund 2018-10-01
Owlstone–Foxconn: investment, 201810 financing round totalling additional $35m incl new + co-investor Foxconn Technology Group 2018-10-01
Owlstone–Horizons Ventures: investment, 201810 financing round totalling additional $35m incl existing + lead investor Horizons Ventures 2018-10-01
Owlstone–SEVERAL: investment, 201810 financing round additional $35m (£27m) bringing total to $50m led by Horizons Ventures 2018-10-01
Owlstone–Ventura Capital: investment, 201810 financing round totalling additional $35m incl new + co-investor Ventura Capital 2018-10-01
VelosBio–Arix Bioscience: investment, 201810 financing round Series A totalling $58m incl $11m from new + co-lead investor Arix Bioscience 2018-10-01
VelosBio–SEVERAL: investment, 201810 financing round Series A $58m co-led by new investors Arix Bioscience + Sofinnova Ventures 2018-10-01
VelosBio–Sofinnova: investment, 201810 financing round Series A totalling $58m incl new + co-lead investor Sofinnova Ventures 2018-10-01
Tusk Therapeutics–Roche: investment, 201809 acquisition for €70m cash + €585m milestones with some assets spun out into Black Belt Therapeutics 2018-09-28
TTP Group–Battery Ventures: investment, 201810 acquisition €na of TTP Labtech from TTP Group by Battery Ventures 2018-09-27
Evotec–Berenberg: investor conference, 201809 supply service Evotec attends 7th German Corporate Conference in Munich 2018-09-26
Nightstar Therapeutics–SEVERAL: investment, 201809 Public Offering $72m+$10.8m with 4m+600k ADS at $18/ADS 2018-09-25
Evotec–Baader Bank: investor conference, 201809 supply service Evotec attends Baader Investment Conference 2018 in Munich 2018-09-24
Histologix–Intelligent Tissue Group: investment, 201809 acquisition of Histologix Ltd by The Intelligent Tissue Group Ltd 2018-09-20
Thermo Fisher–ERS Genomics: CRISPR technology, 201809– license ww non-excl rights to products + tools + services for research from ERS Genomics 2018-09-18
GamaMabs Pharma–Andrew Lloyd Associates: public relations, 201809 service existent by ALA 2018-09-17
AstraZeneca–Horizon Discovery: genomic libraries, 201809– supply adoption of Edit-R crRNA libraries for funcitonal genomics discovery platform by AZ 2018-09-14
Applied Microarrays–Novacyt: DNA microarrays, 201809– €na collab developm probes for customised SNP microarrys by Primerdesign 2018-09-13
Evotec–JPMorgan Chase: investor conference, 201809 supply service Evotec at JP Morgan Cazenove Pan-European Small/Mid Cap Conference London 2018-09-12
Cell Medica–United Kingdom (govt): cell therapy manfucturing, 201809 supply existent Cell Medica uses CGT Catapult manufacturing centre in Stevenage 2018-09-11
Freeline Therapeutics–United Kingdom (govt): gene therapy manfucturing, 201809 supply Freeline uses CGT Catapult manufacturing centre in Stevenage 2018-09-11
Optibrium–Intellegens: drug discovery software, 201809– collab providing Optibrium clients access to Intellegens’ Alchemite AI technology 2018-09-11
Arecor–Albion Ventures: investment, 201809 financing round totalling £6m incl co-lead investor Albion Capital 2018-09-10
Arecor–Calculus Capital: investment, 201809 financing round totalling £6m incl co-lead investor Calculus Capital 2018-09-10
Arecor–Downing Ventures: investment, 201809 financing round totalling £6m incl co-lead investor Downging Ventures 2018-09-10
Arecor–SEVERAL: investment, 201809 financing round £6m co-led by Calculus Capital + Downing Ventures + Albion Capital 2018-09-10
Merck (DE)–AstraZeneca: digital pathology, 201809– collab multi-year partnership with Definiens using TissuePhenomics for biomarker quantification 2018-09-10
Evotec–Goldman Sachs: investor conference, 201809 supply service Evotec at 8th Annual Biotech Symposium in London 2018-09-07
Novate Medical–BTG: investment, 201809 acquisition $20m cash upfront + $130m milestones of Novate Medical Ltd by BTG plc 2018-09-07
Uniqure–Goldman Sachs: investor conference, 201809 supply service Uniqure presents at 8th Annual Biotech Symposium in London 2018-09-07
Adaptimmune–Matrix Capital Manamagent: investment, 201809 registered direct offering totalling $100m incl existing investor Matrix Capital 2018-09-05
Adaptimmune–New Enterprise Associates: investment, 201809 registered direct offering totalling $100m incl existing investor NEA 16 LP + NEA 14 LP 2018-09-05
Adaptimmune–SEVERAL: investment, 201809 registered direct offering $100m of 10m ADSs at $10/ADS to Matrix Capital + NEA + Syncona 2018-09-05
Adaptimmune–Wellcome Trust: investment, 201809 registered direct offering totalling $100m incl new investor Syncona Portfolio Ltd 2018-09-05
Azeria Therapeutics–Sixth Element Capital: investment, 201709 Series A investment £4m from CRT Pioneer Fund 2018-09-04
Optibrium–Enamine: chemical compound libraries, 201809– collab free access to EnamineStore database for StarDrop users 2018-09-04
Evox Therapeutics–Alphabet: investment, 201809 financing round Series B totalling £35.5m incl new investor GV 2018-09-03
Evox Therapeutics–Borealis Ventures: investment, 201809 financing round Series B totalling £35.5m incl new investor Borealis Ventures 2018-09-03
Evox Therapeutics–Cowen: investment, 201809 financing round Series B totalling £35.5m incl new investor Cowen Healthcare Investments 2018-09-03
Evox Therapeutics–Panacea Healthcare Venture: investment, 201809 financing round Series B totalling £35.5m incl new investor PHV 2018-09-03
Evox Therapeutics–Redmile Group: investment, 201809 financing round Series B totalling £35.5m incl new + lead investor Redmile Group 2018-09-03
Evox Therapeutics–SEVERAL: investment, 201809 financing round Series B totalling £35.5m incl small number of private investors 2018-09-03
Evox Therapeutics–SEVERAL: investment, 201809 financing round Series B £35.5m led by Redmile Group 2018-09-03
Evox Therapeutics–Univ Oxford: investment, 201809 financing round Series B totalling £35.5m incl existing investors OSI + Oxford Univ 2018-09-03
Genomics Medicine Ireland–Univ Cambridge: genomics, 201808– collab using 15000 DNA-extracted MS samples from biobank of Prof Sawcer 2018-08-30
Genomics plc–FTI Consulting: public relations, 201808 service existent by FTI Consulting 2018-08-30
Genomics plc–Invesco: investment, 201808 financing round Series B totalling £25m incl existing + co-investor Invesco Perpetual 2018-08-30
Genomics plc–IP Group: investment, 201808 financing round Series B totalling £25m incl existing + co-investor IP Group 2018-08-30
Genomics plc–Lansdowne Partners: investment, 201808 financing round Series B totalling £25m incl existing + co-investor Lansdowne Partners 2018-08-30
Genomics plc–SEVERAL: investment, 201808 financing round Series B £25m led by Vertex + incl IP Group + Woodford et al 2018-08-30
Genomics plc–Tanarra: investment, 201808 financing round Series B totalling £25m incl co-investor Tamorer Pty Ltd 2018-08-30
Genomics plc–Univ Oxford: investment, 201808 financing round Series B totalling £25m incl co-investor Oxford Sciences Innovation 2018-08-30
Genomics plc–Vertex: investment, 201808 financing round Series B totalling £25m incl lead investor Vertex in connection with collab 2018-08-30
Genomics plc–Woodford Investment: investment, 201808 financing round Series B totalling £25m incl existing + co-investor Woodford Investment 2018-08-30
Lunaphore–SEVERAL: investment, 201808 financing round Series B CHF5.3m from existing + new investors 2018-08-30
Vertex–Genomics plc: bioinformatics, 201808– collab expansion using human genetics + data science for target discovery + personalised medicine 2018-08-30
Kandy Therapeutics–Advent Venture Partners: investment, 201808 financing round Series C totalling £25m incl existing investor Advent Life Sciences 2018-08-29
Kandy Therapeutics–Forbion: investment, 201808 financing round Series C totalling £25m incl existing investor Forbion Capital Partners 2018-08-29
Kandy Therapeutics–Fountain Healthcare Partners: investment, 201808 financing round Series C totalling £25m incl existing investor Fountain HCP 2018-08-29
Kandy Therapeutics–Longitude Capital: investment, 201808 financing round Series C totalling £25m incl new investor Longitude Capital 2018-08-29
Kandy Therapeutics–OrbiMed Advisors: investment, 201808 financing round Series C totalling £25m incl existing investor OrbiMed 2018-08-29
Kandy Therapeutics–SEVERAL: investment, 201808 financing round Series C £25m from Longitude Capital + Advent LS + Fountain HCP + Forbion + OrbiMed 2018-08-29
Nebula Genomics–Heartbeat Labs: investment, 201808 seed financing round totalling $4.3m incl Heartbeat Labs 2018-08-29
Nebula Genomics–Hikma: investment, 201808 seed financing round totalling $4.3m incl Hikma Ventures 2018-08-29
Nebula Genomics–SEVERAL: investment, 201808 seed financing round $4.3m from ten leading tech + biotech VCs 2018-08-29
Congenica–Instinctif Partners: public relations, 201808 service existent by Instinctif 2018-08-28
Thermo Fisher–BioStrata: public relations, 201808 service existent by BioStrata 2018-08-27
SolasCure–BRAIN: investment, 201808 financing round Series A with participation of BRAIN at spin-off of SolasCure from BRAIN 2018-08-22
SolasCure–BRAIN: wound care product, 201808– license IP for Aurase enzyme + supply of enzymatic active ingredient by BRAIN to SolasCure 2018-08-22
SolasCure–SEVERAL: investment, 201808 financing round Series A with participation of BRAIN 2018-08-22
Ziylo–Novo Group: investment, 201808 acquisition 100% for up to $800m in upfront + milestone payments by Novo Nordisk 2018-08-17
Abzena–Welsh Carson Anderson & Stowe: investment, 201808– recommended cash offer 16p/share valueing Abzena at £34.4m by WCAS XII-Astra LP 2018-08-16
Blueberry Therapeutics–Bryan Garnier: financial services, 201808 supply service financial advisor with regard to £10m Series B financing round 2018-08-14
Blueberry Therapeutics–China Medial System: investment, 201808 financing round Series B totalling £10m incl China Medical Venture Investment (HK) Ltd 2018-08-14
Blueberry Therapeutics–Onyx Health: public relations, 201808 service existent by Onyx Health PR 2018-08-14
Blueberry Therapeutics–PERSON: investment, 201808 financing round Series B totalling £10m incl investor A&B (HK) Ltd 2018-08-14
Blueberry Therapeutics–SEVERAL: investment, 201808 financing round Series B £10m from China Medical Venture Investment + A&B (HK) 2018-08-14
Blueberry Therapeutics–Slater Heelis: legal services, 201808 supply service legal advisor with regard to £10m Series B financing round 2018-08-14
Orchard Therapeutics–SEVERAL: investment, 201808 financing round Series C $150m led by Deerfield Management 2018-08-13
Artios Pharma–AbbVie: investment, 201808 financing round Series B totalling $84m incl existing + co-investor AbbVie Ventures 2018-08-10
Artios Pharma–Andera Partners: investment, 201808 financing round Series B totalling $84m (£65m) incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Arix Bioscience: investment, 201808 financing round Series B totalling $84m incl existing + co-investor Arix Bioscience 2018-08-10
Artios Pharma–IP Group: investment, 201808 financing round Series B totalling $84m incl existing + co-investor IP Group 2018-08-10
Artios Pharma–Life Sciences Partners: investment, 201808 financing round Series B totalling $84m incl new + lead investors Andera Partners + LSP 2018-08-10
Artios Pharma–Merck (DE): investment, 201808 financing round Series B totalling $84m incl existing + co-investor M Ventures 2018-08-10
Artios Pharma–Novartis: investment, 201808 financing round Series B totalling $84m incl new + co-investor Novartis Venture Fund 2018-08-10
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29  next pagenext page



Advertisement

Picture EBD Group Bio-Europe 2018 Copenhagen Denmark November 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px

» top